Summer

Lab automation: New Modalities

More visitors, more exhibitors and more new product launches at SLAS Europe in Hamburg.

Highlights included the latest developments in CRISPR automation, toxicity and phenotypic screening in human 3D cell aggregates and the presentation of a completely new protease-resistant and highly specific oral drug class.

In this Focus:

  • Finding new leads and modalities automatically
  • Spiroligomer molecules: advancing drug design
  • Remote controls for immunotherapies

ADVERTISEMENT

Other issues

Special Winter 2026426EB_Gene editing
Special Winter 2026426EB_Radiopharmaceuticals
Special Autumn 2026326EB_CROs&CDMOs_cover
Special Autumn 2026EBM 3.2026 Autumn Special Autoimmune_cover
Special Autumn 2026326EB_Spezial_Spanien_L
Special Summer 2026226EB_Spezial_RNA Technologies_cover

ADVERTISEMENT

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!